MSD
The Development and Commercialization Team Leader is responsible for delivering an integrated CMC development and commercialization strategy for the company's biologics portfolio, ensuring the successful launch of a target commercial product. This role involves leading the DCT, managing end-to-end execution of deliverables, and driving cross-functional collaboration to mitigate risks and achieve regulatory and operational success. The position requires strong technical expertise, strategic thinking, and leadership to oversee processes from early development through commercial manufacturing.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Development and Commercialization Team (DCT) Leader
Merck & Co., Inc.
CMC Project Leader, Vaccines and Immune Therapies (V&I), BioPharmaceutical Development
AstraZeneca
Vice President, Biologics Process Development
Ipsen
CMC Project Leader, Vaccines and Immune Therapies (V&I), BioPharmaceutical Development
AstraZeneca
CMC Project Leader, Oncology, BioPharmaceutical Development (Director)
AstraZeneca
Associate Director, Biologics New Product Commercialization
Merck & Co., Inc.